GlassScriptPhysician profile
Collette B Brown
NPI 1174982235
$2,700.51
in general payments reported to CMS, 2019-2025
16 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $370 · 2023: $1,423 · 2024: $420 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881 · Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.50 |
| Travel and Lodging | $450.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $450.29 | 2023 | 3m Ioban, V.A.C. Veraflo, 3m Cavilon |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $263.56 | 2023-2025 | |
| Abbvie INC. | $248.69 | 2023-2025 | |
| Novo Nordisk INC | $240.70 | 2022-2023 | |
| Viiv Healthcare Company | $220.39 | 2024-2025 | Cabenuva |
| Takeda Pharmaceuticals U.S.A., INC. | $192.77 | 2023 | Livtencity |
| Genzyme Corporation | $128.42 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2023 | Abilify Maintena |
| Ani Pharmaceuticals, INC. | $125.00 | 2024 | Purified Cortrophin Gel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2023 | Xifaxan |
| Gilead Sciences, INC. | $124.97 | 2022 | |
| Glaxosmithkline, LLC. | $122.91 | 2023 | Arexvy |
| Viatris Specialty LLC | $121.96 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $100.00 | 2023 | Terlivaz |
| Boston Scientific Corporation | $91.85 | 2024 | Wavewriter Alpha Prime 16 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $19.00 | 2023 | Gore Synecor Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collette Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.